Strathspey Crown Establishes Ceyeber Corporation
Ocular Smart Implant Technology Company
News provided by
Share this article
Share this article
NEWPORT BEACH, Calif., April 22, 2021 /PRNewswire/ With emerging technology based on a strong IP portfolio, Ceyeber has established itself as a unique advanced human cybernetics Company. The Company is fully privately funded with a strong internal team of experts in the field.
Ceyeber is the developer of implantable intraocular lens technology designed for medical applications and augmented reality. The Company is currently in the research and development phase of creating medical-grade ocular smart implantables that integrate cellular, WIFI and 802.11 transmissions in a cognitive interface, enabling clients to enhance cognitive functions and digitally capture experiences and individual memories. The company has developed a benchtop working prototype of their U.S. Patent No. 9,662,199 B2, which covers an implantable intraocular le
/PRNewswire/ Todays Health Science, a new player in the digital health space, is officially entering the health and wellness conversation. Todays Health.
Share this article
Share this article
PITTSBURGH, April 20, 2021 /PRNewswire/ We wanted to create an improved location monitoring system to safeguard Alzheimer s patients, said one of two inventors, from Harvey, LA., so we invented the ALZHEIMER S ALERT. Our stylish design encourages Alzheimer s patients to wear the monitoring device on a daily basis.
The invention provides an effective way for a caregiver to monitor the location of an Alzheimer s patient. In doing so, it offers an attractive alternative to traditional medical-style bracelets and devices. As a result, it increases precision and it provides added safety and peace of mind. The invention features a fashionable and functional design that is easy to wear and use so it is ideal for Alzheimer s patients, caregivers and care facilities. Additionally, it is producible in design variations and a prototype is available.
Share this article
NEW YORK, April 21, 2021 /PRNewswire/
We hated to admit that we could never drink safely. But in A.A. we finally gave up trying to control our drinking. What once had felt like a solution to our problems had become a problem beyond what we could ever have imagined. And often we were the last to know.
We discovered that we had an illness called alcoholism - often referred to by the medical community as Alcohol Use Disorder.
Download the Meeting Guide app to find a meeting near you (PRNewsfoto/Alcoholics Anonymous World Services, Inc.)
We found out that many people suffered from the same feelings of guilt, loneliness and hopelessness that we did.
SimonMed Partners with American Securities
News provided by
Share this article
Share this article
SCOTTSDALE, Ariz. and NEW YORK, April 21, 2021 /PRNewswire/ SimonMed Imaging ( SimonMed ), one of the largest independent outpatient medical imaging providers and physician radiology practices in the United States, and American Securities LLC, a leading U.S. private equity firm, today announced a strategic partnership that includes an investment from American Securities to support continued growth. Financial terms of the transaction were not disclosed.
Based in Scottsdale, Arizona and founded in 2002 by Dr. John Simon, SimonMed operates 147 diagnostic medical imaging centers across 11 states that offer the full modality of diagnostic scans, including 3T MRI, CT, ultrasound, 3-D mammography, PET/CT, nuclear medicine, DEXA, and X-rays. SimonMed s integrated technical and professional business model includes operating the centers where imaging scans are performed and employing subspe